Connection
Jeffrey Swigris to Interleukin-13
This is a "connection" page, showing publications Jeffrey Swigris has written about Interleukin-13.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.166 |
|
|
|
-
Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, Belloni P, Swigris JJ. Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2021 02; 57(2).
Score: 0.166